AzTrials
AzTrials

Health AdultsNCT07627113

Prenatal Androgen and Skills

An observational study of Health Adults, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Due to the difficulties and risks of directly measuring prenatal hormone levels, biomarkers that indirectly reflect this exposure are used in research. In this context, the ratio of second to fourth finger length (2D:4D) is widely preferred because it is an easily applicable and non-invasive measurement. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Health Adults
What is being tested?
Digit Ratio, Fine motor skills and Tactile Discrimination
How many people
94 participants
Where
1 siteTurkey (Türkiye)
Study dates
6 Oct 2026to 1 Jul 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: - Healthy individuals aged 18-40

Who may be able to join

  • Healthy individuals aged 18-40
  • Having sufficient visual and auditory function to understand and administer the test,
  • Voluntary agreement to participate in the study and providing informed consent.

Who cannot join

  • Individuals with any musculoskeletal pathology,
  • History of upper extremity trauma,
  • Individuals diagnosed with metabolic, neurological, or genetic diseases,
  • Individuals with a history of hand surgery within the last 6 months,
  • Pregnancy or breastfeeding.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Rabia Zorlular contact

rabiaeraslan118@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Nigde Omer Halisdemir University

    Niğde, Merkez

    Rabia ZORLULAR, rabiaeraslan118@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Prenatal Androgen and Fine Motor Skills and Tactile Discrimination

Due to the difficulties and risks of directly measuring prenatal hormone levels, biomarkers that indirectly reflect this exposure are used in research. In this context, the ratio of second to fourth finger length (2D:4D) is widely preferred because it is an easily applicable and non-invasive measurement. Evidence shows that 2D:4D stabilizes from the second trimester of pregnancy onward and exhibits strong sex differences across populations. The 2D:4D ratio is generally lower in men than in women. 2D is more strongly influenced by prenatal estrogen, while 4D is more strongly influenced by prenatal testosterone; this occurs during the first trimester of intrauterine fetal development. To our knowledge, studies examining the relationship between the 2D:4D ratio, an indirect indicator of prenatal androgen exposure, and dexterity and tactile discrimination are limited. Accordingly, the planned study aims to evaluate the relationship between the 2D:4D ratio and fine motor skills and tactile discrimination in healthy young adults.

Read the detailed description

Sex hormones experienced during prenatal exposure play a significant role in shaping certain lifelong characteristics by influencing both the physical and neurological development of individuals. The effects of these hormones, particularly on the developing nervous system, contribute to the emergence of behavioral and functional differences. Hand preference and certain behavioral traits in humans have been shown to be related to prenatal hormonal exposure. However, the development of these traits is not limited to hormonal influences alone, but is shaped by the interaction of genetic, environmental, and sociocultural factors. Due to the difficulties and risks of directly measuring prenatal hormone levels, biomarkers that indirectly reflect this exposure are used in research. In this context, the ratio of second to fourth finger length (2D:4D) is widely preferred because it is an easily applicable and non-invasive measurement. The 2D:4D ratio is generally lower in men than in women. 2D is more strongly influenced by prenatal estrogen, while 4D is more strongly influenced by prenatal testosterone; this occurs during the first trimester of intrauterine fetal development. However, whether the 2D:4D ratio is a reliable indicator of prenatal hormonal exposure is still a controversial issue in the literature. Therefore, examining the relationship between the 2D:4D ratio and various biological and functional characteristics remains important. To our knowledge, studies examining the relationship between the 2D:4D ratio, an indirect indicator of prenatal androgen exposure, and dexterity and tactile discrimination are limited. Accordingly, the planned study aims to evaluate the relationship between the 2D:4D ratio and fine motor skills and tactile discrimination in healthy young adults. It is hypothesized that prenatal hormonal exposure may indirectly shape finger morphology and receptor distribution by affecting skin and nervous system development, which may be a determining factor in tactile sensitivity and dexterity.

Conditions
Health Adults
Being tested
Digit Ratio, Fine motor skills, Tactile Discrimination
Keywords
Digit Ratios, Prenatal Androgens, Motor Skills, Two-Point Discrimination, Tactile Acuity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digit RatioOther

    The second (2D) and fourth (4D) finger lengths of the participants will be measured separately in both hands by a physiotherapist with over thirteen years of clinical experience.

  • Fine motor skillsBehavioural

    Hand dexterity will be assessed using the Purdue Pegboard Test. The test will be administered according to standard procedure with participants seated at a table. Participants will be asked to place the pegs into the corresponding holes as quickly and accurately as possible within a specified time (30 seconds).

  • Tactile DiscriminationBehavioural

    To perform the 2-point discrimination tests, the Baseline® two-point discriminator will be used. Measurements will be applied to the distal phalangeal pulp of the index finger on both hands while participants are seated in a comfortable position with their eyes closed.

Study groups in NCT07627113
Study groupRoleWhat they receive
Healthy adultsYoung and healthy adults aged 18-40
Receives: Other: Digit Ratio; Behavioral: Fine motor skills; Behavioral: Tactile Discrimination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 2-point discrimination test

    To perform 2-point discrimination tests, the Baseline® two-point discriminator will be used. Measurements will be applied to the distal phalangeal pulp of the index finger on both hands while participants are seated in a comfortable position with their eyes closed. The test will begin at a distance of 8 mm, allowing participants to perceive the stimulus as two points, and then the distance will be gradually reduced. After 5 mm, measurements will continue at 1 mm intervals. In each application, both contact points will be applied to the skin simultaneously and with equal pressure, and participants will be asked to indicate whether the perceived stimulus is a single point or two points.

    Measured: 12 months

  2. Digit Ratio

    Measurements will be taken after participants' hands are placed on a flat surface with palms facing upwards. Finger length is defined as the distance from the midpoint of the proximal crease line where the finger joins the palm to the distal point of the fingertip.

    Measurements will be performed using a digital caliper with 0.01 mm accuracy, two separate measurements will be taken for each finger, and the average value will be recorded. Based on the obtained measurements, the 2D:4D finger ratio will be calculated by dividing the 2D length by the 4D length in both hands .

    Measured: 12 months

  3. Fine motor skills

    The test will be administered according to standard procedure while participants are seated at a table. Participants will be asked to place the pegs into the corresponding holes as quickly and accurately as possible within the specified time (30 seconds). In the dominant and non-dominant hand tests, participants will be asked to place pegs with one hand for 30 seconds, while in the both-hand test, the simultaneous use of both hands will be evaluated. The number of correctly placed pegs for each subtest will be recorded, and higher scores will be considered as better fine motor skill performance.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2026
  2. Study start6 Oct 2026
  3. Primary completion1 Jul 2027 (estimated)
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
94 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07627113
Sponsor's protocol ID
Androgen and Skills
Status last verified
May 2026
First submitted
30 May 2026
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Butovskaya M, Adam Y, Batsevich V, Shackelford TK, Fink B. Associations between 2D:4D from direct and radiographic measurements with handgrip strength in young adult Tuvans. Early Hum Dev. 2024 Jun;193:106037. doi: 10.1016/j.earlhumdev.2024.106037. Epub 2024 May 8.

    PubMed 38743999
  • Fink B, Manning JT, Neave N, Tan U. Second to fourth digit ratio and hand skill in Austrian children. Biol Psychol. 2004 Nov;67(3):375-84. doi: 10.1016/j.biopsycho.2004.03.012.

    PubMed 15294393

Questions about this trial

What is this clinical trial studying?

An observational study of Health Adults, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rabia ZORLULAR (+5424362082, rabiaeraslan118@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

2-point discrimination test (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07627113, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in